_id
69109847ccc777a4e85d5c08
Ticker
ERGO
Name
Entia Biosciences Inc
Exchange
PINK
Address
13565 SW Tualatin-Sherwood Road, Sherwood, OR, United States, 97140
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.entiabio.com
Description
Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the United States. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical foods, nutraceuticals, cosmetics, and other products. The company's portfolio of formulations include ErgoD2, a pharmaceutical grade organic compound from whole food that contains the micro-nutrients; L-Ergothioneine, a naturally occurring amino acid and master antioxidant; and vitamin D, an antioxidant. In addition, it is also developing products for the chronic kidney disease and other diseases, as well as providing cosmeceuticals and other beauty products under the GROH brand name. Entia Biosciences, Inc. offers its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was founded in 2007 and is headquartered in Sherwood, Oregon.
Last Close
0.0003
Volume
-
Current Price
0.0003
Change
-50
Last Updated
2026-01-03T11:07:55.968Z
Image
-
Ipo Date
-
Market Cap
10098
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2016-12-31
Revenue
45986
Cost Of Revenue
10120
Gross Profit
35866
Operating Expenses
371606
Operating Income
-335740
Interest Expense
43596
Pretax Income
-432777
Net Income
-469743
Eps
-0.016689438304187107
Dividends Per Share
0
Shares Outstanding
33660947
Income Tax Expense
36966
EBITDA
-385692
Operating Margin
-730.0917670595398
Total Other Income Expense Net
-97037
Cash
76050
Short Term Investments
0
Receivables
7973
Inventories
69759
Total Current Assets
234347
Property Plant Equipment
18285
Total Assets
439141
Payables
652.65
Short Term Debt
745922
Long Term Debt
300078
Total Liabilities
2405702
Equity
-1966561
Bs_currency_symbol
USD
Depreciation
3493
Change In Working Capital
-105962
Cash From Operations
-439956
Capital Expenditures
0
Cash From Investing
0
Cash From Financing
513986
Net Change In Cash
74030
Cf_currency_symbol
USD
PE
-
PB
-0.004293707238168559
ROE
23.886520682551925
ROA
-106.96860461674041
FCF
-439956
Fcf Percent
-9.56717261775323
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
2
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
6.3
Garp Investing Score
3
Growth Investing Score
2.5
Momentum Investing Score
5
Net Net Investing Score
2
Quality Investing Score
2
Value Investing Score
2.5
Quarters > 0 > quarter
2016-12-31
Quarters > 0 > income Statement > revenue
45986
Quarters > 0 > income Statement > cost Of Revenue
10120
Quarters > 0 > income Statement > gross Profit
35866
Quarters > 0 > income Statement > operating Expenses
371606
Quarters > 0 > income Statement > operating Income
-335740
Quarters > 0 > income Statement > interest Expense
43596
Quarters > 0 > income Statement > pretax Income
-432777
Quarters > 0 > income Statement > net Income
-469743
Quarters > 0 > income Statement > eps
-0.016689438304187107
Quarters > 0 > income Statement > dividends Per Share
0
Quarters > 0 > income Statement > shares Outstanding
28146124
Quarters > 0 > income Statement > income Tax Expense
36966
Quarters > 0 > income Statement > EBITDA
-385692
Quarters > 0 > income Statement > operating Margin
-730.0917670595398
Quarters > 0 > income Statement > total Other Income Expense Net
-97037
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
76050
Quarters > 0 > balance Sheet > short Term Investments
0
Quarters > 0 > balance Sheet > receivables
7973
Quarters > 0 > balance Sheet > inventories
69759
Quarters > 0 > balance Sheet > total Current Assets
234347
Quarters > 0 > balance Sheet > property Plant Equipment
18285
Quarters > 0 > balance Sheet > total Assets
439141
Quarters > 0 > balance Sheet > payables
652.65
Quarters > 0 > balance Sheet > short Term Debt
745922
Quarters > 0 > balance Sheet > long Term Debt
300078
Quarters > 0 > balance Sheet > total Liabilities
2405702
Quarters > 0 > balance Sheet > equity
-1966561
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-432777
Quarters > 0 > cash Flow > depreciation
3493
Quarters > 0 > cash Flow > change In Working Capital
-105962
Quarters > 0 > cash Flow > cash From Operations
-439956
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
0
Quarters > 0 > cash Flow > cash From Financing
513986
Quarters > 0 > cash Flow > net Change In Cash
74030
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.016689438304187107
Quarters > 0 > ratios > PB
-0.004293707238168559
Quarters > 0 > ratios > ROE
23.886520682551925
Quarters > 0 > ratios > ROA
-106.96860461674041
Quarters > 0 > ratios > FCF
-439956
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-9.56717261775323
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2016-09-30
Quarters > 1 > income Statement > revenue
41855
Quarters > 1 > income Statement > cost Of Revenue
13429
Quarters > 1 > income Statement > gross Profit
28426
Quarters > 1 > income Statement > operating Expenses
299799
Quarters > 1 > income Statement > operating Income
-271373
Quarters > 1 > income Statement > interest Expense
14634
Quarters > 1 > income Statement > pretax Income
-288776
Quarters > 1 > income Statement > net Income
-303410
Quarters > 1 > income Statement > eps
-0.010781288237621995
Quarters > 1 > income Statement > dividends Per Share
0
Quarters > 1 > income Statement > shares Outstanding
28142277
Quarters > 1 > income Statement > income Tax Expense
14634
Quarters > 1 > income Statement > EBITDA
-269409
Quarters > 1 > income Statement > operating Margin
-648.3645920439612
Quarters > 1 > income Statement > total Other Income Expense Net
-17403
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
2020
Quarters > 1 > balance Sheet > short Term Investments
0
Quarters > 1 > balance Sheet > receivables
5730
Quarters > 1 > balance Sheet > inventories
28669
Quarters > 1 > balance Sheet > total Current Assets
72644
Quarters > 1 > balance Sheet > property Plant Equipment
21779
Quarters > 1 > balance Sheet > total Assets
365827
Quarters > 1 > balance Sheet > payables
691.31
Quarters > 1 > balance Sheet > short Term Debt
254175
Quarters > 1 > balance Sheet > long Term Debt
298647
Quarters > 1 > balance Sheet > total Liabilities
2009336
Quarters > 1 > balance Sheet > equity
-1643509
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-288779
Quarters > 1 > cash Flow > depreciation
4734
Quarters > 1 > cash Flow > change In Working Capital
180943
Quarters > 1 > cash Flow > cash From Operations
-73614
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
0
Quarters > 1 > cash Flow > cash From Financing
57876
Quarters > 1 > cash Flow > net Change In Cash
-15738
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.010781288237621995
Quarters > 1 > ratios > PB
-0.005136986228855454
Quarters > 1 > ratios > ROE
18.461109735328495
Quarters > 1 > ratios > ROA
-82.93811009028857
Quarters > 1 > ratios > FCF
-73614
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-1.7587862859873373
Quarters > 1 > health Score
29
Quarters > 2 > quarter
2016-06-30
Quarters > 2 > income Statement > revenue
98425
Quarters > 2 > income Statement > cost Of Revenue
35593
Quarters > 2 > income Statement > gross Profit
62832
Quarters > 2 > income Statement > operating Expenses
353181
Quarters > 2 > income Statement > operating Income
-290349
Quarters > 2 > income Statement > interest Expense
17888
Quarters > 2 > income Statement > pretax Income
-401631
Quarters > 2 > income Statement > net Income
-419519
Quarters > 2 > income Statement > eps
-0.014909060449397368
Quarters > 2 > income Statement > dividends Per Share
0
Quarters > 2 > income Statement > shares Outstanding
28138527
Quarters > 2 > income Statement > income Tax Expense
17888
Quarters > 2 > income Statement > EBITDA
-379008
Quarters > 2 > income Statement > operating Margin
-294.995173990348
Quarters > 2 > income Statement > total Other Income Expense Net
-18208
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
17758
Quarters > 2 > balance Sheet > short Term Investments
0
Quarters > 2 > balance Sheet > receivables
9956
Quarters > 2 > balance Sheet > inventories
13080
Quarters > 2 > balance Sheet > total Current Assets
81881
Quarters > 2 > balance Sheet > property Plant Equipment
25414
Quarters > 2 > balance Sheet > total Assets
399798
Quarters > 2 > balance Sheet > payables
659.2
Quarters > 2 > balance Sheet > short Term Debt
193323
Quarters > 2 > balance Sheet > long Term Debt
297215
Quarters > 2 > balance Sheet > total Liabilities
1789856
Quarters > 2 > balance Sheet > equity
-1390058
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-401634
Quarters > 2 > cash Flow > depreciation
4735
Quarters > 2 > cash Flow > change In Working Capital
261703
Quarters > 2 > cash Flow > cash From Operations
-102335
Quarters > 2 > cash Flow > capital Expenditures
2588
Quarters > 2 > cash Flow > cash From Investing
-2588
Quarters > 2 > cash Flow > cash From Financing
122681
Quarters > 2 > cash Flow > net Change In Cash
17758
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.014909060449397368
Quarters > 2 > ratios > PB
-0.006072809983468315
Quarters > 2 > ratios > ROE
30.179963713744318
Quarters > 2 > ratios > ROA
-104.93274103422227
Quarters > 2 > ratios > FCF
-104923
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-1.066019812039624
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2016-03-31
Quarters > 3 > income Statement > revenue
79200
Quarters > 3 > income Statement > cost Of Revenue
32357
Quarters > 3 > income Statement > gross Profit
46843
Quarters > 3 > income Statement > operating Expenses
316754
Quarters > 3 > income Statement > operating Income
-269911
Quarters > 3 > income Statement > interest Expense
7394
Quarters > 3 > income Statement > pretax Income
-272592
Quarters > 3 > income Statement > net Income
-279986
Quarters > 3 > income Statement > eps
-0.009957254215294283
Quarters > 3 > income Statement > dividends Per Share
0
Quarters > 3 > income Statement > shares Outstanding
28118796
Quarters > 3 > income Statement > income Tax Expense
7394
Quarters > 3 > income Statement > EBITDA
-265176
Quarters > 3 > income Statement > operating Margin
-340.7967171717172
Quarters > 3 > income Statement > total Other Income Expense Net
-2681
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
0
Quarters > 3 > balance Sheet > short Term Investments
0
Quarters > 3 > balance Sheet > receivables
9506
Quarters > 3 > balance Sheet > inventories
31219
Quarters > 3 > balance Sheet > total Current Assets
85708
Quarters > 3 > balance Sheet > property Plant Equipment
29050
Quarters > 3 > balance Sheet > total Assets
405772
Quarters > 3 > balance Sheet > payables
616.18
Quarters > 3 > balance Sheet > short Term Debt
208681
Quarters > 3 > balance Sheet > long Term Debt
152827
Quarters > 3 > balance Sheet > total Liabilities
1432408
Quarters > 3 > balance Sheet > equity
-1026636
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-272592
Quarters > 3 > cash Flow > depreciation
4735
Quarters > 3 > cash Flow > change In Working Capital
145589
Quarters > 3 > cash Flow > cash From Operations
-99193
Quarters > 3 > cash Flow > capital Expenditures
4529
Quarters > 3 > cash Flow > cash From Investing
-4529
Quarters > 3 > cash Flow > cash From Financing
79589
Quarters > 3 > cash Flow > net Change In Cash
-24133
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.009957254215294283
Quarters > 3 > ratios > PB
-0.008216776734889483
Quarters > 3 > ratios > ROE
27.2721782598701
Quarters > 3 > ratios > ROA
-69.00081819346825
Quarters > 3 > ratios > FCF
-103722
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-1.309621212121212
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2022-12-31
Annuals > 0 > income Statement > revenue
-
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
-
Annuals > 0 > income Statement > operating Income
-
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-
Annuals > 0 > income Statement > net Income
-
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
28136527
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
-
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
-
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
-
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
-
Annuals > 0 > balance Sheet > equity
-
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-
Annuals > 0 > cash Flow > depreciation
228485
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-
Annuals > 0 > cash Flow > capital Expenditures
-
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
-
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
-
Annuals > 0 > ratios > ROA
-
Annuals > 0 > ratios > FCF
-
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
45
Annuals > 1 > quarter
2021-12-31
Annuals > 1 > income Statement > revenue
-
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
-
Annuals > 1 > income Statement > operating Income
-
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-
Annuals > 1 > income Statement > net Income
-
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
28136527
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
-
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
-
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
-
Annuals > 1 > balance Sheet > payables
-
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
-
Annuals > 1 > balance Sheet > equity
-
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
-
Annuals > 1 > cash Flow > depreciation
236558
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-
Annuals > 1 > cash Flow > capital Expenditures
-
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
-
Annuals > 1 > cash Flow > currency_symbol
-
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
-
Annuals > 1 > ratios > ROA
-
Annuals > 1 > ratios > FCF
-
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
45
Annuals > 2 > quarter
2020-12-31
Annuals > 2 > income Statement > revenue
-
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
-
Annuals > 2 > income Statement > operating Income
-
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-
Annuals > 2 > income Statement > net Income
-
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
28136527
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
-
Annuals > 2 > balance Sheet > cash
-
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
-
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
-
Annuals > 2 > balance Sheet > payables
-
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
-
Annuals > 2 > balance Sheet > equity
-
Annuals > 2 > balance Sheet > currency_symbol
-
Annuals > 2 > cash Flow > net Income
-
Annuals > 2 > cash Flow > depreciation
206297
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
-
Annuals > 2 > cash Flow > capital Expenditures
-
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
-
Annuals > 2 > cash Flow > net Change In Cash
-
Annuals > 2 > cash Flow > currency_symbol
-
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
-
Annuals > 2 > ratios > ROA
-
Annuals > 2 > ratios > FCF
-
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
45
Annuals > 3 > quarter
2019-12-31
Annuals > 3 > income Statement > revenue
-
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
-
Annuals > 3 > income Statement > operating Income
-
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-
Annuals > 3 > income Statement > net Income
-
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
28136527
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
-
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
-
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
-
Annuals > 3 > balance Sheet > payables
-
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
-
Annuals > 3 > balance Sheet > equity
-
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
-
Annuals > 3 > cash Flow > depreciation
171860
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
-
Annuals > 3 > cash Flow > capital Expenditures
-
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
-
Annuals > 3 > cash Flow > net Change In Cash
-
Annuals > 3 > cash Flow > currency_symbol
-
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
-
Annuals > 3 > ratios > ROE
-
Annuals > 3 > ratios > ROA
-
Annuals > 3 > ratios > FCF
-
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
45
Valuation > metrics > PE
-0.016689438304187107
Valuation > metrics > PB
-0.004293707238168559
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
23.886520682551925
Profitability > metrics > ROA
-200.44762680981623
Profitability > metrics > Net Margin
-10.214913234462662
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-7.701165244517846
Risk > final Score
-1
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.3138962727973686
Liquidity > metrics > Quick Ratio
0.22045752558032877
Liquidity > final Score
21
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
37
Prev Profitabilities > 1
40
Prev Profitabilities > 2
40
Prev Risks > 0
-44
Prev Risks > 1
-35
Prev Risks > 2
-116
Prev Liquidities > 0
19
Prev Liquidities > 1
28
Prev Liquidities > 2
23
Updated At
2026-01-22T21:10:15.897Z
Earnings History > 0 > period
2016-12-31
Earnings History > 0 > report Date
2016-12-31
Earnings History > 0 > date
2016-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-0.0154
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2016-09-30
Earnings History > 1 > report Date
2016-12-31
Earnings History > 1 > date
2016-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.0154
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2016-06-30
Earnings History > 2 > report Date
2016-09-30
Earnings History > 2 > date
2016-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.0103
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2016-03-31
Earnings History > 3 > report Date
2016-06-30
Earnings History > 3 > date
2016-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.0143
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2015-12-31
Earnings History > 4 > report Date
2016-03-31
Earnings History > 4 > date
2015-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.0097
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2015-09-30
Earnings History > 5 > report Date
2015-12-31
Earnings History > 5 > date
2015-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.0104
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2015-06-30
Earnings History > 6 > report Date
2015-09-30
Earnings History > 6 > date
2015-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.013
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2015-03-31
Earnings History > 7 > report Date
2015-06-30
Earnings History > 7 > date
2015-03-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.0459
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2014-12-31
Earnings History > 8 > report Date
2015-03-31
Earnings History > 8 > date
2014-12-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.0507
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2014-09-30
Earnings History > 9 > report Date
2014-12-31
Earnings History > 9 > date
2014-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.064
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2014-06-30
Earnings History > 10 > report Date
2014-09-30
Earnings History > 10 > date
2014-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.0553
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2014-03-31
Earnings History > 11 > report Date
2014-06-30
Earnings History > 11 > date
2014-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.0599
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2013-12-31
Earnings History > 12 > report Date
2014-03-31
Earnings History > 12 > date
2013-12-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.0643
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2013-09-30
Earnings History > 13 > report Date
2013-12-31
Earnings History > 13 > date
2013-09-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.1448
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2013-06-30
Earnings History > 14 > report Date
2013-09-30
Earnings History > 14 > date
2013-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.0714
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2013-03-31
Earnings History > 15 > report Date
2013-06-30
Earnings History > 15 > date
2013-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.1393
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2012-12-31
Earnings History > 16 > report Date
2013-03-31
Earnings History > 16 > date
2012-12-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.0609
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2012-09-30
Earnings History > 17 > report Date
2012-12-31
Earnings History > 17 > date
2012-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.038
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2012-06-30
Earnings History > 18 > report Date
2012-09-30
Earnings History > 18 > date
2012-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.0389
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2012-03-31
Earnings History > 19 > report Date
2012-06-30
Earnings History > 19 > date
2012-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.0546
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2011-12-31
Earnings History > 20 > report Date
2012-03-31
Earnings History > 20 > date
2011-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.0449
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2011-09-30
Earnings History > 21 > report Date
2011-12-31
Earnings History > 21 > date
2011-09-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.0963
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2011-06-30
Earnings History > 22 > report Date
2011-09-30
Earnings History > 22 > date
2011-06-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.0324
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2011-03-31
Earnings History > 23 > report Date
2011-06-30
Earnings History > 23 > date
2011-03-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.0343
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2010-12-31
Earnings History > 24 > report Date
2011-03-31
Earnings History > 24 > date
2010-12-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.1115
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2010-09-30
Earnings History > 25 > report Date
2010-12-31
Earnings History > 25 > date
2010-09-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.0623
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2010-06-30
Earnings History > 26 > report Date
2010-06-30
Earnings History > 26 > date
2010-06-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.0512
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2010-03-31
Earnings History > 27 > report Date
2010-03-31
Earnings History > 27 > date
2010-03-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.058
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2009-12-31
Earnings History > 28 > report Date
2009-12-31
Earnings History > 28 > date
2009-12-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.0527
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2009-09-30
Earnings History > 29 > report Date
2009-09-30
Earnings History > 29 > date
2009-09-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.0364
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2009-06-30
Earnings History > 30 > report Date
2009-06-30
Earnings History > 30 > date
2009-06-30
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-0.0169
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2009-03-31
Earnings History > 31 > report Date
2009-03-31
Earnings History > 31 > date
2009-03-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.0299
Earnings History > 31 > eps Estimate
-
Earnings History > 31 > eps Difference
0
Earnings History > 31 > surprise Percent
-
Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the United States. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical foods, nutraceuticals, cosmetics, and other products. The company's portfolio of formulations include ErgoD2, a pharmaceutical grade organic compound from whole food that contains the micro-nutrients; L-Ergothioneine, a naturally occurring amino acid and master antioxidant; and vitamin D, an antioxidant. In addition, it is also developing products for the chronic kidney disease and other diseases, as well as providing cosmeceuticals and other beauty products under the GROH brand name. Entia Biosciences, Inc. offers its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was founded in 2007 and is headquartered in Sherwood, Oregon.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AGjensidige completes sale of Baltic operations to ERGO, boosting solvency MSN
Read more →Sale of Gjensidige's Baltic operations completed TradingView — Track All Markets
Read more →Showing 2 of 10
(Last Updated 2016-12-31)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Entia Biosciences Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2016-12-31
EPS Actual
-0.0154
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2016-12-31)
(Last Updated 2016-12-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2016-12-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2016-12-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.